Faron Pharmaceuticals Limited (AIM:FARN) says 43% of high-risk MDS patients now show full remission after treatment with bexmarilimab and azacitidine. That’s a major jump from the 28% figure reported earlier in its ongoing clinical trial. Read more
ImmuPharma PLC (AIM:IMM) is in talks with global partners after fresh data confirmed its autoimmune drug P140 works without suppressing the immune system. Releasing its interim results, the company said it also plans to expand its patent portfolio to strengthen future licensing deals. Read more
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) has completed early works at its Tulu Kapi gold project in Ethiopia and says full development is close. A $240 million financing deal is nearly wrapped up, with contracts now ready to sign. Read more
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) has launched a £1 million retail raise following shareholder approval for a £10 million institutional deal. The funding will support the next phase of helium exploration in Tanzania and the US. Read more
Satsuma Technology PLC (LSE:SATS) has raised £163.6 million in an oversubscribed funding round, smashing its £100 million target. Big-name investors like Pantera, Kraken, and DCG joined in, with over £96 million settled in Bitcoin. Read more
Incanthera PLC (AQSE:INC) is launching its Skin + CELL skincare brand on 11 August via a new e-commerce site. The digital campaign is already live, targeting an audience of over 40 million through influencer channels. Read more
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
